There's been a major selloff in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) shares in the week since it released its full-year report, with the stock down 26% to US$2.35. The statutory results were ...
Source LinkThere's been a major selloff in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) shares in the week since it released its full-year report, with the stock down 26% to US$2.35. The statutory results were ...
Source Link
Comments